EANS-Tip Announcement: Marinomed Biotech AG / Quarterly report according to art. 126 Stock Exchange Act

--------------------------------------------------------------------------------
Tip announcement for financial statements transmitted by euro adhoc with the
aim of a Europe-wide distribution. The issuer is responsible for the content
of this announcement.
--------------------------------------------------------------------------------

The company Marinomed Biotech AG is declaring the following financial reports
below:

Report Type: Quarterly report according to art. 126 Stock Exchange Act
English:
Publication Date: 29.11.2019
Publication Location: https://www.marinomed.com/en/investors/publications

Further inquiry note:
Dr. Eva Prieschl-Grassauer
Chief Scientific Officer, Marinomed
Veterinärplatz 1, 1210 Vienna, Austria
T +43 (0)1 250 77 4460
E-Mail: [email protected]
http://www.marinomed.com

Roland Mayrl
Managing Partner, Metrum Communications
Bauernmarkt 10/19, 1010 Vienna, Austria
T +43 (0) 1 504 69 87 331
E-Mail: [email protected]
http://www.metrum.at

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: [email protected]
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English

ORIGINAL APA-OTS TEXT - THE INFORMATION CONTAINED IN THIS PRESS RELEASE IS SUBJECT TO THE EXCLUSIVE RESPONSIBILITY OF THE ISSUER | EAE

print